Phosplatin honored at the European Society of Medical Oncology (ESMO) 2018 Annual Meeting
The first-in-human Phase I study was honored as the best poster presentation among all developmental therapeutics at the European Society of Medical Oncology (ESMO) 2018 Annual Meeting in Munich, Germany.